AMCP 2020

Presentations

Brentuximab Vedotin | Lymphoma | Abstract C35

Real-World Treatment Patterns and Overall Survival Among Medicare Fee-For-Service Beneficiaries Newly Diagnosed With Peripheral T-Cell Lymphoma